235 related articles for article (PubMed ID: 27159171)
1. Haploidentical HCT using an αβ T-cell-depleted graft with targeted αβ(+) cells by add-back after a reduced intensity preparative regimen containing low-dose TBI.
Im HJ; Koh KN; Suh JK; Lee SW; Choi ES; Jang S; Kwon SW; Park CJ; Seo JJ
Bone Marrow Transplant; 2016 Sep; 51(9):1217-22. PubMed ID: 27159171
[TBL] [Abstract][Full Text] [Related]
2. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
3. TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia.
Maschan M; Shelikhova L; Ilushina M; Kurnikova E; Boyakova E; Balashov D; Persiantseva M; Skvortsova Y; Laberko A; Muzalevskii Y; Kazachenok A; Glushkova S; Bobrynina V; Kalinina V; Olshanskaya Y; Baidildina D; Novichkova G; Maschan A
Bone Marrow Transplant; 2016 May; 51(5):668-74. PubMed ID: 26808573
[TBL] [Abstract][Full Text] [Related]
4. Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation study.
Choi I; Yoon SR; Park SY; Kim H; Jung SJ; Jang YJ; Kang M; Yeom YI; Lee JL; Kim DY; Lee YS; Kang YA; Jeon M; Seol M; Lee JH; Lee JH; Kim HJ; Yun SC; Lee KH
Biol Blood Marrow Transplant; 2014 May; 20(5):696-704. PubMed ID: 24525278
[TBL] [Abstract][Full Text] [Related]
5. Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center.
Dufort G; Castillo L; Pisano S; Castiglioni M; Carolina P; Andrea I; Simon E; Zuccolo S; Schelotto M; Morosini F; Pereira I; Amarillo P; Silveira A; Guerrero L; Ferreira V; Tiscornia A; Mezzano R; Lemos F; Boggia B; Quarnetti A; Decaro J; Dabezies A
Bone Marrow Transplant; 2016 Oct; 51(10):1354-1360. PubMed ID: 27272446
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimen.
Jacoby E; Varda-Bloom N; Goldstein G; Hutt D; Churi C; Vernitsky H; Toren A; Bielorai B
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988422
[TBL] [Abstract][Full Text] [Related]
7. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
Front Immunol; 2020; 11():699. PubMed ID: 32477328
[TBL] [Abstract][Full Text] [Related]
8. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
[TBL] [Abstract][Full Text] [Related]
9. Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose.
Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Lee JW
Am J Hematol; 2018 Nov; 93(11):1368-1375. PubMed ID: 30117176
[TBL] [Abstract][Full Text] [Related]
10. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
Yahng SA; Kim JH; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
Biol Blood Marrow Transplant; 2015 Jan; 21(1):119-29. PubMed ID: 25300871
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of HLA-haploidentical stem cell transplantation based on an FBCA conditioning regimen compared with those of HLA-identical sibling stem cell transplantation for haematologic malignancies.
Long H; Lu ZG; Song CY; Huang YX; Xu JH; Xu JX; Deng L; Tu SF; He YZ; Lin X; Guo KY; Wu BY
Bone Marrow Transplant; 2016 Nov; 51(11):1470-1475. PubMed ID: 27322852
[TBL] [Abstract][Full Text] [Related]
13. Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.
Li Pira G; Malaspina D; Girolami E; Biagini S; Cicchetti E; Conflitti G; Broglia M; Ceccarelli S; Lazzaro S; Pagliara D; Meschini A; Bertaina A; Montanari M; Locatelli F
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2056-2064. PubMed ID: 27519279
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of HLA-haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion based on an FBCA conditioning regimen for hematologic malignancies.
Lin X; Lu ZG; Song CY; Huang YX; Guo KY; Deng L; Tu SF; He YZ; Xu JH; Long H; Wu BY
Bone Marrow Transplant; 2015 Aug; 50(8):1092-7. PubMed ID: 25961770
[TBL] [Abstract][Full Text] [Related]
15. Comparable Outcome with a Faster Engraftment of Optimized Haploidentical Hematopoietic Stem Cell Transplantation Compared with Transplantations from Other Donor Types in Pediatric Acquired Aplastic Anemia.
Kim H; Im HJ; Koh KN; Kang SH; Yoo JW; Choi ES; Cho YU; Jang S; Park CJ; Seo JJ
Biol Blood Marrow Transplant; 2019 May; 25(5):965-974. PubMed ID: 30639824
[TBL] [Abstract][Full Text] [Related]
16. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
Mehta PA; Davies SM; Leemhuis T; Myers K; Kernan NA; Prockop SE; Scaradavou A; O'Reilly RJ; Williams DA; Lehmann L; Guinan E; Margolis D; Baker KS; Lane A; Boulad F
Blood; 2017 Apr; 129(16):2308-2315. PubMed ID: 28179273
[TBL] [Abstract][Full Text] [Related]
17. T-cell receptor αβ
Shah RM; Elfeky R; Nademi Z; Qasim W; Amrolia P; Chiesa R; Rao K; Lucchini G; Silva JMF; Worth A; Barge D; Ryan D; Conn J; Cant AJ; Skinner R; Abd Hamid IJ; Flood T; Abinun M; Hambleton S; Gennery AR; Veys P; Slatter M
J Allergy Clin Immunol; 2018 Apr; 141(4):1417-1426.e1. PubMed ID: 28780238
[TBL] [Abstract][Full Text] [Related]
18. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
[TBL] [Abstract][Full Text] [Related]
19. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
Zecca M; Strocchio L; Pagliara D; Comoli P; Bertaina A; Giorgiani G; Perotti C; Corbella F; Brescia L; Locatelli F
Biol Blood Marrow Transplant; 2014 Apr; 20(4):571-6. PubMed ID: 24462983
[TBL] [Abstract][Full Text] [Related]
20. Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ
Gaziev J; Isgrò A; Sodani P; Paciaroni K; De Angelis G; Marziali M; Ribersani M; Alfieri C; Lanti A; Galluccio T; Adorno G; Andreani M
Blood Adv; 2018 Feb; 2(3):263-270. PubMed ID: 29431621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
